Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 2, 2022
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
Tue, March 1, 2022
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
[ Tue, Mar 01st 2022
] - WOPRAI
Bradley Canino Maintained (ALXO) at Strong Buy with Decreased Target to $36 on, Mar 1st, 2022
Bradley Canino of Stifel, Maintained "ALX Oncology Holdings Inc." (ALXO) at Strong Buy with Decreased Target from $60 to $36 on, Mar 1st, 2022.
Bradley has made no other calls on ALXO in the last 4 months.
There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, all agrees with Bradley's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Wednesday, December 22nd, 2021
